R. Jude Samulski, Ph.D., was honored by the American Society of Gene + Cell Therapy (ASGCT) with its Founders Award at the ...
North Carolina Agricultural and Technical State University will collaborate with another historically Black college and ...
The Alexandria Center for Life Science - Durham North Campus (ACLS-D), at 42 Moore Drive, won the distinction. It’s located ...
Frontier Scientific Solutions has committed close to a billion dollars in infrastructure at the Wilmington Airport, with ...
Durham-based BioCryst Pharmaceuticals, a global biotechnology company focused on developing and commercializing medicines for ...
A California medical technology startup plans to expand the Research Triangle Park facility it bought in 2022, adding 50 jobs and spending up to $65 million on the project. Science Corp. in Alameda, ...
Fresh off a new funding round, Durham startup Ten63 Therapeutics is looking to advance its technology platform that uses artificial intelligence to unlock discoveries for difficult-to-treat cancers.
An Israeli pharmaceutical company with U.S. headquarters in Raleigh says it’s on track to seek regulatory approval for potentially lucrative new uses of its variation on a common gastrointestinal drug ...
Biopesticide startup Innatrix is on a quest to develop environmentally friendly products to control crop diseases and pests. The Research Triangle Park-based business hopes to secure $3 million in ...
Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and Drug Administration for its first product – a groundbreaking bioengineered ...
Durham-based BioCryst Pharmaceuticals Inc. is advancing care for children living with hereditary angioedema (HAE) as it begins a new chapter under a new CEO. The company recently received approval ...
With roots in the research labs at North Carolina State University, ChromaGenix has opened a new $35 million, 6,500-square-foot research and development and manufacturing facility at NC State’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results